So A cytokine storm is an overproduction of immune cells and their activating compounds (cytokines), which, in a flu infection, is often associated with a surge of activated immune cells into the lungs. The resulting lung inflammation and fluid buildup can lead to respiratory distress and can be contaminated by a secondary bacterial pneumonia -- often enhancing the mortality in patients.
Proteins may halt the severe cytokine storms seen in COVID-19 patients
Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections
- April 16, 2020
- Massachusetts Institute of Technology
- A team of researchers has developed specialized antibody-like receptor proteins that they believe could soak up the excess cytokines produced during a cytokine storm. This excessive immune response, sometimes seen in Covid-19 patients, can be fatal.
- https://www.sciencedaily.com/releases/2020/04/200416135950.htm
- cytokine/ˈsʌɪtə(ʊ)kʌɪn/nounPHYSIOLOGY
- any of a number of substances, such as interferon, interleukin, and growth factors, which are secreted by certain cells of the immune system and have an effect on other cells.
A few months back I watched David Icke explain in a program that what actually is killing people isn't the virus but, in the elderly and those with different health conditions, (and those with certain dna markers) it was a 'Stressed' auto immune reaction to the virus which presents as a sudden and violent release of cytokines. This 'storm of cytokines' White blood cells and fighter cells set to kill invading cells, will flood in a aggressive response to the detection of a viral entity in the body. Cytokines do this. That's what they do, it is Usually a normal healthy response. But to bodies that have endured years of stress and or over medication, (think: elderly person, living through years of enduring situations etc, 19 medications per day) and the same for people whose health has been compromised by stress or an overexposure to chemicals etc etc. the immune response will be a flair up of cytokines, as in a storm, and it is this which has the capacity to kill. It is the pathway that an already compromised immune system will inevitably go down, and is significantly higher for certain types of people that have certain biological markers that will be predisposed to a cytokine storm 'emergency room' situation...when they have come across infection with a virulent virus. AND...and it is true too, when a small amount of 'dead' Virulent virus (with other foreign ingredients, in a vaccine) is injected into these already stress/health compromised people or those with culturally identified biological markers that will trigger such a cytokine storm release, which can and do kill.....
In both a 'natural' situation of an organic, randomly 'occurring in nature', 'biologically aggressive' and in an unnatural situation whereby a virus has been manipulated to swarm and mutate in an aggressive manner, then it is especially difficult to determine a death directly from the virus...or death by this cytokine storm, as it floods to lungs, triggered by the virus.
It seems that some types of 'genes on the protein of a flu virus (a marker) actively can, and do strongly activate this cytokine storm response in certain types of individuals: So certain genes are known to activate cytokine storms when certain types of people are infected wuth certain types of flu virus. i.e they are a Known component of a flu virus.
evidence in mice that infection with influenza virus carrying the HA gene from the 1918 virus seems to strongly activate some immune cells to over-produce a half dozen or more cytokines
Weathering the cytokine storm in COVID-19: Telltale signs, therapeutic hope on the horizon
Randy Q. Cron
Good news about COVID-19 is at a premium these days. Encouraging reports about therapeutic options or vaccine development usually are either overly optimistic or entirely spurious. But scientific advancement is as relentless as the virus itself, and this is exemplified by a growing body of research into a potential association between cytokine storm syndrome and COVID-19.
Randy Q. Cron, MD, PhD, of the Children’s Hospital of Alabama and the University of Alabama at Birmingham, described cytokine storm syndrome as an “overly exuberant” immune response to something like a viral infection or cancer. While it is not currently known why some patients with COVID-19 demonstrate this response and others do not, plenty is known about these inflammatory immunologic proteins and how they have reacted in other disease states, many of them rheumatologic conditions.
Deadly immune 'storm' caused by emergent flu infections
- February 27, 2014
- The Scripps Research Institute
- Scientists have mapped key elements of a severe immune overreaction -— a “cytokine storm” -— that can both sicken and kill patients who are infected with certain strains of flu virus. A cytokine storm is an overproduction of immune cells and their activating compounds (cytokines), which, in a flu infection, is often associated with a surge of activated immune cells into the lungs. The resulting lung inflammation and fluid buildup can lead to respiratory distress and can be contaminated by a secondary bacterial pneumonia -- often enhancing the mortality in patients.
- Scientists at The Scripps Research Institute (TSRI) have mapped key elements of a severe immune overreaction -- a "cytokine storm" -- that can both sicken and kill patients who are infected with certain strains of flu virus.
Their findings, published in this week's online Early Edition of the Proceedings of the National Academy of Sciences, also clarify the workings of a potent new class of anti-inflammatory compounds that prevent this immune overreaction in animal models.
"We show that with this type of drug, we can quiet the storm enough to interfere with the virus-induced disease and lung injury, while still allowing the infected host to mount a sufficient immune response to eliminate the virus," said John R. Teijaro, an assistant professor in TSRI's Department of Immunology and Microbial Science and first author of the study.
"This study provides insights into mechanisms that are chemically tractable and can modulate these cytokine storms," said Hugh Rosen, professor in TSRI's Department of Chemical Physiology and senior author of the study with Michael B. A. Oldstone, professor in TSRI's Department of Immunology and Microbial Science.
Calming the Storm
A cytokine storm is an overproduction of immune cells and their activating compounds (cytokines), which, in a flu infection, is often associated with a surge of activated immune cells into the lungs. The resulting lung inflammation and fluid buildup can lead to respiratory distress and can be contaminated by a secondary bacterial pneumonia -- often enhancing the mortality in patients.
This little-understood phenomenon is thought to occur in at least several types of infections and autoimmune conditions, but it appears to be particularly relevant in outbreaks of new flu variants. Cytokine storm is now seen as a likely major cause of mortality in the 1918-20 "Spanish flu" -- which killed more than 50 million people worldwide -- and the H1N1 "swine flu" and H5N1 "bird flu" of recent years. In these epidemics, the patients most likely to die were relatively young adults with apparently strong immune reactions to the infection -- whereas ordinary seasonal flu epidemics disproportionately affect the very young and the elderly.
For the past eight years, Rosen's and Oldstone's laboratories have collaborated in analyzing the cytokine storm and finding treatments for it. In 2011, led by Teijaro, who was then a research associate in the Oldstone Lab, the TSRI team identified endothelial cells lining blood vessels in the lungs as the central orchestrators of the cytokine storm and immune cell infiltration during H1N1 flu infection.
In a separate study, the TSRI researchers found that they could quiet this harmful reaction in flu-infected mice and ferrets by using a candidate drug compound to activate immune-damping receptors (S1P1 receptors) on the same endothelial cells. This prevented most of the usual mortality from H1N1 infection -- and did so much more effectively than the existing antiviral drug oseltamivir, although the combination of both therapies worked even better. "That was really the first demonstration that inhibiting the cytokine storm is protective," said Teijaro.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.